Clinical Partnerships Neotropix focuses on treating neuroendocrine cancers with systemically delivered oncolytic viruses, creating opportunities for early-phase clinical collaborations with academic medical centers and biopharma to access trial sites, patient populations, and regulatory expertise.

Manufacturing Readiness To commercialize viral therapies, Neotropix will need GMP manufacturing, process development, and robust supply chains; there are sales opportunities with CMOs, CDMOs, and CROs offering viral vector production, fill finish, QC, and regulatory support.

Incubator Space As a mid-sized biotech, Neotropix could leverage accelerator programs or shared lab facilities to access wet labs, equipment, and investor networks while accelerating product development.

Funding Opportunities With revenue in the low-to-mid range and strong oncology potential, Neotropix could attract venture investment, strategic partnerships, and SBIR/STTR grants to fund clinical milestones and manufacturing scale-up.

Security Compliance Neotropix already emphasizes cybersecurity with Cloudflare and security headers, presenting a chance to partner on data management, clinical trial IT, and regulatory-compliant cloud solutions to support data integrity and safety reporting.